The Esophageal Doppler is the gold standard for minimally invasive hemodynamic management. Using ultrasound to measure precisely the rate of blood flow in the descending aorta enabling you to make the right intervention for your patient. EDM is the only technology that provides a real time response on central circulation and is clinically proven to reduce complications and improve patient outcomes.
Helping you identify the problem before it becomes a crisis.
The technology has established an incomparable evidence base that has resulted in recommendations by government entities, health payers and technology assessment bodies including the Agency for Healthcare & Quality (AHRQ) and the National Institute for Health and Care Excellence (NICE). Studies specifically using EDM have proven patients suffer fewer and less severe complications after surgery and recover more quickly and more fully.
The Centers for Medicare & Medicaid Services (CMS) issued a National Coverage Decision for EDM that resulted in reimbursement for physicians using EDM. This is based on the compelling and robust evidence base of clinical and economic benefits of EDM specifically
Deltex Medical’s CardioQ-EDM™ and CardioQ-EDM+ ™ esophageal Doppler monitors (EDM) change the way hospital clinicians can care for surgical and critical care patients. When used to guide Fluid Management during surgery the products reduce complications, shorten length of stay and cut hospital costs.